DOMINICI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 3.863
EU - Europa 1.102
AS - Asia 517
AF - Africa 19
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.520
Nazione #
US - Stati Uniti d'America 3.842
IT - Italia 328
SE - Svezia 248
UA - Ucraina 212
SG - Singapore 206
IN - India 196
FI - Finlandia 114
CN - Cina 109
DE - Germania 60
IE - Irlanda 49
GB - Regno Unito 30
CA - Canada 20
TG - Togo 15
AR - Argentina 14
BE - Belgio 13
BG - Bulgaria 11
FR - Francia 8
NL - Olanda 7
GR - Grecia 6
AT - Austria 3
BH - Bahrain 2
CH - Svizzera 2
ES - Italia 2
EU - Europa 2
PL - Polonia 2
RO - Romania 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BR - Brasile 1
CL - Cile 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
TR - Turchia 1
Totale 5.520
Città #
Fairfield 634
Woodbridge 404
Ashburn 296
Chandler 284
Seattle 280
Houston 259
Cambridge 207
Wilmington 206
Ann Arbor 152
Rome 134
Singapore 132
Princeton 108
Plano 101
Lawrence 97
Jacksonville 94
San Paolo di Civitate 92
Beijing 88
Boston 69
Dublin 49
San Diego 47
Andover 34
Norwalk 29
Des Moines 28
Grafing 28
Millbury 26
Dearborn 22
Falls Church 16
Helsinki 15
Lomé 15
Federal 14
Santa Clara 13
Fremont 12
New York 12
Sofia 11
Toronto 11
Brussels 9
Bremen 7
Bühl 7
Boardman 6
Bologna 5
Buffalo 5
Mannheim 5
Montréal 5
Phoenix 5
San Mateo 5
Sant'agata De' Goti 5
Castel Madama 4
Hefei 4
London 4
Los Angeles 4
Pune 4
Albano Laziale 3
Fort Worth 3
Milan 3
Munich 3
Nanjing 3
Palermo 3
Redmond 3
Terni 3
Vienna 3
Waanrode 3
Auburn Hills 2
Chicago 2
Chiswick 2
Foligno 2
Fuzhou 2
Galdo 2
Indiana 2
Jinan 2
Kilburn 2
Livorno 2
Madrid 2
Messina 2
New Bedfont 2
Ottawa 2
Redwood City 2
San Giuliano Milanese 2
Southend 2
Termoli 2
Turin 2
Abano Terme 1
Acton 1
Aquila 1
Argenta 1
Auckland 1
Bari 1
Basking Ridge 1
Bern 1
Busto Arsizio 1
Chengdu 1
Chongqing 1
Cologne 1
Cotonou 1
Dallas 1
Essen 1
Falkenstein 1
Ghedi 1
Guangzhou 1
Guelph 1
Hangzhou 1
Totale 4.191
Nome #
Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma 183
Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition 114
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 105
Expression of Glial Cell Line-Derived Neurotrophic Factor and Neurturin in Mature Kidney, Nephrogenic Rests, and Nephroblastoma: Possible Role as Differentiating Factors 101
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 99
Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression 97
A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma 95
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation 95
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 93
Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells 88
Bim-dependent apoptosis follows IGFBP-5 down-regulation in neuroblastoma cells 86
A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors. 84
Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience 80
ASSOCIATION OF NEAR-DIPLOID DNA CONTENT AND N-MYC AMPLIFICATION IN NEUROBLASTOMAS 78
Cytomegalovirus-associated stage 4S neuroblastoma relapsed stage 4. 77
Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88. 77
Carboplatin and doxorubicin (CARDOX) for non metastatic hepatoblastoma: a discouraging pilot study. 76
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. 76
Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: Pharmacological rationale and clinical response 74
Chemotherapeutic agent cisplatin monitoring in biological fluids by means of inductively-coupled plasma emission spectrometry (ICP-AES). 72
Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. 70
Somatostatin in neuroblastoma and ganglioneuroma 69
Adrenocorticotropic hormone-secreting ganglioneuroblastoma associated with opsomyoclonic encephalopathy: a case report with immunohistochemical study. 69
Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells 69
Different pattern of matrix metalloproteinases expression in alveolar versus embryonal rhabdomyosarcoma 68
Correlation between tyrosine hydroxylase immunoreactive cells in tumors and urinary catecholamine output in neuroblastoma patients. 68
RAS Signaling Dysregulation in Human Embryonal Rhabdomyosarcoma 66
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells 66
Vascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcoma 65
Synergistic Post-Transcriptional Regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 Specific Binding 65
Establishment and characterization of a human neuroblastoma cell line. 65
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 65
Elevated levels of miR-145 correlate with SMAD3 down-regulation in Cystic Fibrosis patients 65
Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma 64
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness 64
Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma 64
Primary pulmonary rhabdomyosarcoma in childhood: clinico-biologic features in two cases with review of the literature. 64
Bilateral rhabdomyomatous tumor relapsed as typical triphasic Wilms' tumor. 63
Neuroblastoma: Contemporary management 62
TRANSCRIPTION OF N-MYC AND PROLIFERATION-RELATED GENES IS LINKED IN HUMAN NEUROBLASTOMA 62
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors 62
Antitumor activity of imatinib mesylate in neuroblastoma xenografts 62
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 61
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform. 60
A PHARMACOKINETIC STUDY OF HIGH-DOSE CONTINUOUS INFUSION CISPLATIN IN CHILDREN WITH SOLID TUMORS 57
Activation of p53-dependent responses in tumour cells treated with a PARC-interacting peptide 56
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: Results of a pilot study on 239 patients 56
KIT gene deletion in a gastrointestinal stromal tumor of the small intestine. 55
MYCN Sensitizes Human Neuroblastoma to Apoptosis by HIPK2 Activation through a DNA Damage Response 55
Malignant pancreatic endocrine tumor in a child with tuberous sclerosis 55
Noonan syndrome-like disorder with loose anagen hair: A second case with neuroblastoma. 54
Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma 54
Long-term Follow-up of the "Wait and See" Approach to Localized Perinatal Adrenal Neuroblastoma 53
Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome. 53
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: Histological, immunohistochemical and molecular features of 15 Italian cases 52
Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis 52
Increased sensitivity to the Platelet-Derived Growth Factor (PDGF) Receptor inhibitor STI571 in chemoresistant high-grade glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation 50
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. 50
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model 50
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line, and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age. 49
PREIRRADIATION CARBOPLATIN AND ETOPOSIDE IN THE TREATMENT OF PAEDIATRIC MEDULLOBLASTOMA IN A SINGLE INSTITUTION 49
Bone marrow micrometastases in a patient with localized Wilms' tumor. 49
Wilms' tumor - Lessons and outcomes - A 25-year single center UK experience 49
Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma 48
[Ewing's sarcoma of the thoracic wall. Description of 7 clinical cases]. 44
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age 44
c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. 42
Clinical significance of CXC chemokine receptor-4 (CXCR4) and c-Met in childhood rhabdomyosarcoma 42
High mobility group Al is a molecular target for MYCN in human neuroblastoma 39
Down-regulation of insulin growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo 38
POLMONITE DA ASPIRAZIONE DI IDROCARBURI Studio istologico ed ultrastrutturale di un caso in età pediatrica 38
Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience. 38
Prolonged response to oral gefitinib, cyclophophamide and topotecan in heavily pretreated relapsed stage 4 neuroblastoma: a case report 36
EFFECTS OF A SINGLE COURSE OF DEFEROXAMINE IN NEUROBLASTOMA PATIENTS 35
Molecular biology of childhood solid tumors: promises maintained and promises postponed 34
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma. 34
Histological and overall response to ICE-CAV dose intensification in newly diagnosed high-risk Ewing sarcoma family tumors: the Bambino Gesù Childrens Hospital experience 33
[Endodermal sinus tumor. Histological changes induced by chemotherapy]. 33
Clinical, analytical and pharmacokinetic aspects in cancer chemotherapy with platinum coordination compounds. 33
Detection and clinical significance of disseminated tumor cells at diagnosis in bone marrow of children with localised rhabdomyosarcoma. 32
Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. 32
[Biological and clinical significance of glycocorticoid receptors in acute lymphatic leukemia]. 31
Determination of Pt in biological samples by inductively coupled plasma atomic emission spectrometry (ICP-AES) with electrothermal vaporization (ETV). 31
Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase. 31
Temozolomide in resistant or relapsed pediatric solid tumors: a monoinstitutional experience 31
[Platinum-based antineoplastic agents: biomedical applications and therapeutic aspects]. 30
Morphological and molecular assesment of apoptotic mechanismsi peripheral neuroblastic tumors (Br.J.Canc.) 30
Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors 30
Imatinib mesylate potentiates topotecan antitumour activity in rhabdomyosarcoma preclinical models 29
Over-expression of miR-494 and miR-145 correlates with CFTR and SMAD3 down-regulation in cystic fibrosis patients 28
[Diagnostic and therapeutic approach in childhood tumors]. 27
MESENCHYMAL CHONDROSARCOMA - A CASE-REPORT IN A 4-YEAR-OLD GIRL 26
Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma 26
[Motilin cells in the intestinal mucosa in celiac disease before, during and after diet therapy. Immunohistochemical study]. 26
Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma 26
HIGH-DOSE CARBOPLATIN WITH ETOPOSIDE (JET REGIMEN) IN CHILDREN WITH ADVANCED NEUROBLASTOMA 25
Peripheral blood stem cells in children with solid tumors. Part I. Feasibility and application. 22
Multidrug resistance gene transcript level, and P-glycoprotein expression in paediatric malignant mesenchymal tumours. 22
Up-regulation of EphB and ephrinB expression in rhabdomyosarcoma tumours 22
[Enteroglucagon cells in the jejunal mucosa in celiac disease, before, during and after diet treatment. Immunohistochemical study]. 21
Totale 5.595
Categoria #
all - tutte 15.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.060 0 0 0 70 117 162 167 160 135 122 89 38
2020/2021582 68 74 26 58 24 41 13 50 40 142 37 9
2021/20221.126 6 79 107 111 136 17 38 108 68 89 159 208
2022/20231.014 186 288 71 105 77 93 21 48 92 5 26 2
2023/2024382 27 58 14 30 34 45 5 32 0 53 34 50
2024/2025144 21 44 55 24 0 0 0 0 0 0 0 0
Totale 5.667